Australian Clinical Labs Ltd (ACL.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Sales | 736,148 | 689,728 | 692,103 | 989,298 | 641,311 |
| Cost of Goods | 128,249 | 119,320 | 126,083 | 207,592 | 119,585 |
| Gross Profit | 607,899 | 570,408 | 566,020 | 781,706 | 521,726 |
| Operating Expenses | 545,016 | 514,496 | 514,053 | 514,029 | 416,536 |
| Operating Income | 62,883 | 55,912 | 51,967 | 267,677 | 105,190 |
| Interest Expense | 3,780 | 4,857 | 3,540 | 1,339 | 10,939 |
| Other Income | -10,924 | -14,689 | -117 | -11,438 | -7,598 |
| Pre-tax Income | 48,179 | 36,366 | 48,310 | 254,900 | 86,653 |
| Income Tax | 15,359 | 12,122 | 12,268 | 76,498 | 26,264 |
| Net Income Continuous | 32,820 | 24,244 | 36,042 | 178,402 | 60,389 |
| Minority Interests | -390 | -310 | -141 | -158 | -16 |
| Net Income | $32,430 | $23,934 | $35,901 | $178,244 | $60,373 |
| EPS Basic Total Ops | 0.17 | 0.12 | 0.18 | 0.89 | 0.40 |
| EPS Basic Continuous Ops | 0.17 | 0.12 | 0.18 | 0.89 | 0.40 |
| EPS Diluted Total Ops | 0.17 | 0.12 | 0.18 | 0.88 | 0.40 |
| EPS Diluted Continuous Ops | 0.17 | 0.12 | 0.18 | 0.88 | 0.40 |
| EBITDA(a) | $188,001 | $169,650 | $174,605 | $362,335 | $185,644 |